This study investigates pancreatic ductal adenocarcinoma. It focuses on developing a non-invasive breath test that detects small molecules, known as volatile organic compounds, produced by pancreatic cancers.
The study evaluates how well this breath test can identify pancreatic cancer in patients referred for further investigations. The focus is on assessing the test's accuracy in detecting cancer-specific compounds.
- Who can participate: Adults aged 18 and over referred from primary care for potential pancreatic cancer can participate. Key exclusions include a history of pancreatic surgery, recent other cancers, pregnancy, and inability to provide consent.
- Study details: Participants will provide breath samples for analysis.
How understandable was the trial content above?
Hard to understand
Easy to understand